|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R97.1 |
Elevated cancer antigen 125 [CA 125]
|
R971 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 9.94%
|
26.57%
|
19.51%
|
13.95%
|
8.91%
|
5.86%
|
3.99%
|
2.92%
|
2.01%
|
1.53%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R97.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
971
|
971
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
891
|
892
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
572
|
572
|
|
80053
|
COMPREHEN METABOLIC PANEL |
512
|
512
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
331
|
331
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
228
|
20,692
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
214
|
214
|
|
83735
|
ASSAY OF MAGNESIUM |
174
|
174
|
|
71260
|
CT THORAX DX C+ |
148
|
148
|
|
82565
|
ASSAY OF CREATININE |
112
|
112
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
96
|
96
|
|
84443
|
ASSAY THYROID STIM HORMONE |
92
|
92
|
|
85027
|
COMPLETE CBC AUTOMATED |
87
|
87
|
|
76830
|
TRANSVAGINAL US NON-OB |
87
|
87
|
|
76856
|
US EXAM PELVIC COMPLETE |
84
|
84
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
78
|
78
|
|
85610
|
PROTHROMBIN TIME |
76
|
76
|
|
80061
|
LIPID PANEL |
75
|
75
|
|
G1004
|
CDSM NDSC |
71
|
92
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
68
|
68
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R97.1 related to the following DRG Codes:
947-948
|
